In breast cancer patients, the low expressions of ETV7-repressed interferon signature genes are associated with worse prognoses [67], suggesting that CSC-mediated suppression of interferon response is correlated with patient’s poor outcomes. This evidence concerns the gene ETV7 and breast cancer.